{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:14:26Z","timestamp":1789996466110,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T00:00:00Z","timestamp":1596931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T00:00:00Z","timestamp":1596931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002261","name":"\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u0424\u043e\u043d\u0434 \u0424\u0443\u043d\u0434\u0430\u043c\u0435\u043d\u0442\u0430\u043b\u044c\u043d\u044b\u0445 \u0418\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0439","doi-asserted-by":"publisher","award":["20-515-00002"],"award-info":[{"award-number":["20-515-00002"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u0424\u043e\u043d\u0434 \u0424\u0443\u043d\u0434\u0430\u043c\u0435\u043d\u0442\u0430\u043b\u044c\u043d\u044b\u0445 \u0418\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0439","doi-asserted-by":"publisher","award":["19-515-25001"],"award-info":[{"award-number":["19-515-25001"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008648","name":"Pfizer Foundation","doi-asserted-by":"publisher","award":["56223641"],"award-info":[{"award-number":["56223641"]}],"id":[{"id":"10.13039\/100008648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["075-15-2019-1669"],"award-info":[{"award-number":["075-15-2019-1669"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10549-020-05827-8","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T18:02:47Z","timestamp":1596996167000},"page":"229-235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients"],"prefix":"10.1007","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6304-1609","authenticated-orcid":false,"given":"Anna P.","family":"Sokolenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana N.","family":"Sokolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria I.","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Preobrazhenskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aglaya G.","family":"Iyevleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana N.","family":"Aleksakhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr A.","family":"Romanko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr A.","family":"Bessonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana V.","family":"Gorodnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena I.","family":"Anisimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena L.","family":"Savonevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya V.","family":"Bizin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya A.","family":"Stepanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr V.","family":"Krivorotko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor V.","family":"Berlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey M.","family":"Belyaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr V.","family":"Togo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny N.","family":"Imyanitov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,9]]},"reference":[{"key":"5827_CR1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/jmedgenet-2015-103672","volume":"53","author":"K Kast","year":"2016","unstructured":"Kast K, Rhiem K, Wappenschmidt B, Hahnen E, Hauke J, Bluemcke B, Zarghooni V, Herold N, Ditsch N, Kiechle M, Braun M, Fischer C, Dikow N, Schott S, Rahner N, Niederacher D, Fehm T, Gehrig A, Mueller-Reible C, Arnold N, Maass N, Borck G, de Gregorio N, Scholz C, Auber B, Varon-Manteeva R, Speiser D, Horvath J, Lichey N, Wimberger P, Stark S, Faust U, Weber BH, Emons G, Zachariae S, Meindl A, Schmutzler RK, Engel C, German Consortium for Hereditary Breast, and Ovarian Cancer (GCHBOC) (2016) Prevalence of BRCA1\/2 germline mutations in 21401 families with breast and ovarian cancer. J Med Genet 53:465\u2013471. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103672","journal-title":"J Med Genet"},{"key":"5827_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/1758834017714993","volume":"9","author":"RT Neff","year":"2017","unstructured":"Neff RT, Senter L, Salani R (2017) BRCA mutation in ovarian cancer: testing, implications and treatment considerations. Ther Adv Med Oncol 9:519\u2013531. https:\/\/doi.org\/10.1177\/1758834017714993","journal-title":"Ther Adv Med Oncol"},{"key":"5827_CR3","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Pichert G, Van t'veer L, Tung N, Weitzel JN, Couch FJ, Rubinstein WS, Ganz PA, Daly MB, Olopade OI, Tomlinson G, Schildkraut J, Blum JL, Rebbeck TR (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304:967\u2013975. https:\/\/doi.org\/10.1001\/jama.2010.1237","journal-title":"JAMA"},{"key":"5827_CR4","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.amjsurg.2016.06.010","volume":"212","author":"KK Ludwig","year":"2016","unstructured":"Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL (2016) Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. Am J Surg 212:660\u2013669. https:\/\/doi.org\/10.1016\/j.amjsurg.2016.06.010","journal-title":"Am J Surg"},{"issue":"suppl 5","key":"5827_CR5","doi-asserted-by":"publisher","first-page":"v103","DOI":"10.1093\/annonc\/mdw327","volume":"27","author":"S Paluch-Shimon","year":"2016","unstructured":"Paluch-Shimon S, Cardoso F, Sessa C, Balmana J, Cardoso MJ, Gilbert F, Senkus E, Guidelines Committee ESMO (2016) Prevention and screening in BRCA mutation carriers and other breast\/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening. Ann Oncol 27(suppl 5):v103\u2013v110. https:\/\/doi.org\/10.1093\/annonc\/mdw327","journal-title":"Ann Oncol"},{"key":"5827_CR6","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nature03443","volume":"434","author":"HE Bryant","year":"2005","unstructured":"Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434:913\u2013917. https:\/\/doi.org\/10.1038\/nature03443","journal-title":"Nature"},{"key":"5827_CR7","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC, Ashworth A (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434:917\u2013921. https:\/\/doi.org\/10.1038\/nature03445","journal-title":"Nature"},{"key":"5827_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10549-014-3100-x","volume":"147","author":"T Byrski","year":"2014","unstructured":"Byrski T, Huzarski T, Dent R, Marczyk E, Jasiowka M, Gronwald J, Jakubowicz J, Cybulski C, Wisniowski R, Godlewski D, Lubinski J, Narod SA (2014) Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Res Treat 147:401\u2013405. https:\/\/doi.org\/10.1007\/s10549-014-3100-x","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5827_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13053-016-0057-2","volume":"14","author":"AG Iyevleva","year":"2016","unstructured":"Iyevleva AG, Imyanitov EN (2016) Cytotoxic and targeted therapy for hereditary cancers. Hered Cancer Clin Pract 14(1):17. https:\/\/doi.org\/10.1186\/s13053-016-0057-2","journal-title":"Hered Cancer Clin Pract"},{"key":"5827_CR10","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1086\/302320","volume":"64","author":"P Hartge","year":"1999","unstructured":"Hartge P, Struewing JP, Wacholder S, Brody LC, Tucker MA (1999) The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet 64:963\u2013970. https:\/\/doi.org\/10.1086\/302320","journal-title":"Am J Hum Genet"},{"key":"5827_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1136\/jmg.39.7.457","volume":"39","author":"H Tulinius","year":"2002","unstructured":"Tulinius H, Olafsdottir GH, Sigvaldason H, Arason A, Barkardottir RB, Egilsson V, Ogmundsdottir HM, Tryggvadottir L, Gudlaugsdottir S, Eyfjord JE (2002) The effect of a single BRCA2 mutation on cancer in Iceland. J Med Genet 39:457\u2013462. https:\/\/doi.org\/10.1136\/jmg.39.7.457","journal-title":"J Med Genet"},{"key":"5827_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/ijc.20162","volume":"110","author":"B G\u00f3rski","year":"2004","unstructured":"G\u00f3rski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, Mackiewicz A, Stawicka M, Bebenek M, Sorokin D, Fiszer-Maliszewska \u0141, Haus O, Janiszewska H, Niepsuj S, G\u00f3\u017ad\u017a S, Zaremba L, Posmyk M, P\u0142uza\u0144ska M, Kilar E, Czudowska D, Wa\u015bko B, Miturski R, Kowalczyk JR, Urba\u0144ski K, Szwiec M, Koc J, Debniak B, Rozmiarek A, Debniak T, Cybulski C, Kowalska E, To\u0142oczko-Grabarek A, Zajaczek S, Menkiszak J, Medrek K, Masoj\u0107 B, Mierzejewski M, Narod SA, Lubi\u0144ski J (2004) A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110:683\u2013686. https:\/\/doi.org\/10.1002\/ijc.20162","journal-title":"Int J Cancer"},{"key":"5827_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10689-014-9721-8","volume":"13","author":"A Savanevich","year":"2014","unstructured":"Savanevich A, Oszurek O, Lubi\u0144ski J, Cybulski C, D\u0119bniak T, Narod SA, Gronwald J (2014) BRCA1 founder mutations compared to ovarian cancer in Belarus. Fam Cancer 13:445\u2013447. https:\/\/doi.org\/10.1007\/s10689-014-9721-8","journal-title":"Fam Cancer"},{"key":"5827_CR14","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.ejca.2006.01.050","volume":"42","author":"AP Sokolenko","year":"2006","unstructured":"Sokolenko AP, Mitiushkina NV, Buslov KG, Bit-Sava EM, Iyevleva AG, Chekmariova EV, Kuligina ESh, Ulibina YM, Rozanov ME, Suspitsin EN, Matsko DE, Chagunava OL, Trofimov DY, Devilee P, Cornelisse C, Togo AV, Semiglazov VF, Imyanitov EN (2006) High frequency of BRCA1 5382insC mutation in Russian breast cancer patients. Eur J Cancer 42:1380\u20131384. https:\/\/doi.org\/10.1016\/j.ejca.2006.01.050","journal-title":"Eur J Cancer"},{"key":"5827_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10689-007-9120-5","volume":"6","author":"AP Sokolenko","year":"2007","unstructured":"Sokolenko AP, Rozanov ME, Mitiushkina NV, Sherina NY, Iyevleva AG, Chekmariova EV, Buslov KG, Shilov ES, Togo AV, Bit-Sava EM, Voskresenskiy DA, Chagunava OL, Devilee P, Cornelisse C, Semiglazov VF, Imyanitov EN (2007) Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia. Fam Cancer 6:281\u2013286. https:\/\/doi.org\/10.1007\/s10689-007-9120-5","journal-title":"Fam Cancer"},{"key":"5827_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.canlet.2010.07.013","volume":"298","author":"AG Iyevleva","year":"2010","unstructured":"Iyevleva AG, Suspitsin EN, Kroeze K, Gorodnova TV, Sokolenko AP, Buslov KG, Voskresenskiy DA, Togo AV, Kovalenko SP, Nv S, Devilee P, Imyanitov EN (2010) Non-founder BRCA1 mutations in Russian breast cancer patients. Cancer Lett 298:258\u2013263. https:\/\/doi.org\/10.1016\/j.canlet.2010.07.013","journal-title":"Cancer Lett"},{"key":"5827_CR17","unstructured":"Golden Helix GenomeBrowse \u00ae visualization tool (Version 2.x) [Software]. Bozeman, MT: Golden Helix, Inc. https:\/\/www.goldenhelix.com."},{"key":"5827_CR18","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jama.2014.5985","volume":"313","author":"TR Rebbeck","year":"2015","unstructured":"Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, Mazoyer S, Chenevix-Trench G, Easton DF, Antoniou AC, Nathanson KL, and the CIMBA Consortium (2015) Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA 313:1347\u20131361. https:\/\/doi.org\/10.1001\/jama.2014.5985","journal-title":"JAMA"},{"key":"5827_CR19","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1245\/s10434-019-07549-8","volume":"26","author":"ER Manahan","year":"2019","unstructured":"Manahan ER, Kuerer HM, Sebastian M, Hughes KS, Boughey JC, Euhus DM, Boolbol SK, Taylor WA (2019) Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons. Ann Surg Oncol 26:3025\u20133031. https:\/\/doi.org\/10.1245\/s10434-019-07549-8","journal-title":"Ann Surg Oncol"},{"key":"5827_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12920-015-0092-2","volume":"8","author":"A Kluska","year":"2015","unstructured":"Kluska A, Balabas A, Paziewska A, Kulecka M, Nowakowska D, Mikula M, Ostrowski J (2015) New recurrent BRCA1\/2 mutations in Polish patients with familial breast\/ovarian cancer detected by next generation sequencing. BMC Med Genomics 8:19. https:\/\/doi.org\/10.1186\/s12920-015-0092-2","journal-title":"BMC Med Genomics"},{"key":"5827_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s13353-011-0040-6","volume":"52","author":"I Brozek","year":"2011","unstructured":"Brozek I, Cybulska C, Ratajska M, Piatkowska M, Kluska A, Balabas A, Dabrowska M, Nowakowska D, Niwinska A, Pamula-Pilat J, Tecza K, Pekala W, Rembowska J, Nowicka K, Mosor M, Januszkiewicz-Lewandowska D, Rachtan J, Grzybowska E, Nowak J, Steffen J, Limon J (2011) Prevalence of the most frequent BRCA1 mutations in Polish population. J Appl Genet 52:325\u2013330. https:\/\/doi.org\/10.1007\/s13353-011-0040-6","journal-title":"J Appl Genet"},{"key":"5827_CR22","doi-asserted-by":"publisher","first-page":"e0201086","DOI":"10.1371\/journal.pone.0201086","volume":"13","author":"A Kowalik","year":"2018","unstructured":"Kowalik A, Sio\u0142ek M, Kopczy\u0144ski J, Krawiec K, Kalisz J, Zi\u0119ba S, Kozak-Klonowska B, Wypi\u00f3rkiewicz E, Furma\u0144czyk J, Nowak-Ozimek E, Ch\u0142opek M, Macek P, Smok-Kalwat J, G\u00f3\u017ad\u017a S (2018) BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1\/2 next-generation sequencing study. PLoS ONE 13:e0201086. https:\/\/doi.org\/10.1371\/journal.pone.0201086","journal-title":"PLoS ONE"},{"key":"5827_CR23","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1002\/ijc.32492","volume":"145","author":"C Cybulski","year":"2019","unstructured":"Cybulski C, Klu\u017aniak W, Huzarski T, Woko\u0142orczyk D, Kashyap A, Rusak B, Stempa K, Gronwald J, Szymiczek A, Bagherzadeh M, Jakubowska A, D\u0119bniak T, Lener M, Rudnicka H, Szwiec M, Jarkiewicz-Tretyn J, Stawicka M, Domaga\u0142a P, Narod SA, Lubi\u0144ski J, Akbari MR, Polish Hereditary Breast Cancer Consortium (2019) The spectrum of mutations predisposing to familial breast cancer in Poland. Int J Cancer 145:3311\u20133320. https:\/\/doi.org\/10.1002\/ijc.32492","journal-title":"Int J Cancer"},{"key":"5827_CR24","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/ijgc-2018-000175","volume":"29","author":"T Gorodnova","year":"2019","unstructured":"Gorodnova T, Sokolenko A, Ni V, Ivantsov A, Kotiv K, Petrik S, Amelina I, Berlev I, Imyanitov E (2019) BRCA1-associated and sporadic ovarian carcinomas: outcomes of primary cytoreductive surgery or neoadjuvant chemotherapy. Int J Gynecol Cancer 29:779\u2013786. https:\/\/doi.org\/10.1136\/ijgc-2018-000175","journal-title":"Int J Gynecol Cancer"},{"key":"5827_CR25","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1097\/IGC.0000000000001352","volume":"28","author":"TV Gorodnova","year":"2018","unstructured":"Gorodnova TV, Kotiv KB, Ivantsov AO, Mikheyeva ON, Mikhailiuk GI, Lisyanskaya AS, Mikaya NA, Guseynov KD, Bondarev NE, Matveyeva NS, Nekrasova EA, Sidoruk AA, Roman LD, Manikhas GM, Belyaev AM, Sokolenko AP, Berlev IV, Imyanitov EN (2018) Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer. Int J Gynecol Cancer 28:1498\u20131506. https:\/\/doi.org\/10.1097\/IGC.0000000000001352","journal-title":"Int J Gynecol Cancer"},{"key":"5827_CR26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10549-017-4357-7","volume":"165","author":"EV Preobrazhenskaya","year":"2017","unstructured":"Preobrazhenskaya EV, Bizin IV, Kuligina ES, Shleykina AY, Suspitsin EN, Zaytseva OA, Anisimova EI, Laptiev SA, Gorodnova TV, Belyaev AM, Imyanitov EN, Sokolenko AP (2017) Detection of BRCA1 gross rearrangements by droplet digital PCR. Breast Cancer Res Treat 165:765\u2013770. https:\/\/doi.org\/10.1007\/s10549-017-4357-7","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5827_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12920-019-0587-3","volume":"12","author":"D Mancini-DiNardo","year":"2019","unstructured":"Mancini-DiNardo D, Judkins T, Kidd J, Bernhisel R, Daniels C, Brown K, Meek K, Craft J, Holladay J, Morris B, Roa BB (2019) Detection of large rearrangements in a hereditary pan-cancer panel using next-generation sequencing. BMC Med Genomics 12(1):138. https:\/\/doi.org\/10.1186\/s12920-019-0587-3","journal-title":"BMC Med Genomics"},{"issue":"2","key":"5827_CR28","doi-asserted-by":"publisher","first-page":"e2150","DOI":"10.7759\/cureus.2150","volume":"10","author":"VM Moiseyenko","year":"2018","unstructured":"Moiseyenko VM, Chubenko VA, Moiseyenko FV, Zagorskaya LA, Zaytseva YA, Gesha NE, Zykov EN, Ni VI, Preobrazhenskaya EV, Sokolenko AP, Imyanitov EN (2018) \u201cLazarus Response\u201d to Olaparib in a Virtually Chemonaive Breast Cancer Patient Carrying Gross BRCA2 Gene Deletion. Cureus 10(2):e2150. https:\/\/doi.org\/10.7759\/cureus.2150","journal-title":"Cureus"},{"key":"5827_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fmolb.2018.00076","volume":"5","author":"AP Sokolenko","year":"2018","unstructured":"Sokolenko AP, Imyanitov EN (2018) Molecular Diagnostics in Clinical Oncology. Front Mol Biosci 5:76. https:\/\/doi.org\/10.3389\/fmolb.2018.00076","journal-title":"Front Mol Biosci"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05827-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-020-05827-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05827-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T23:26:38Z","timestamp":1628465198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-020-05827-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,9]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["5827"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-05827-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,9]]},"assertion":[{"value":"4 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study design was approved by the local Ethical Committee. All procedures performed in study were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}